Macrogenics (MGNX) Enterprise Value (2013 - 2026)

Macrogenics (MGNX) has reported Enterprise Value for 15 consecutive years, with -$66.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Enterprise Value rose 54.31% year-over-year to -$66.5 million; the TTM figure through Mar 2026 stood at -$66.5 million (up 54.31% YoY), while the FY2025 annual figure was -$57.2 million, up 68.71% from the prior year.
• Enterprise Value fell to -$66.5 million in Q1 2026 per MGNX's latest filing, from -$57.2 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$21.5 million in Q2 2022 and bottomed at -$224.3 million in Q1 2023.
• Historically, Enterprise Value has averaged -$105.4 million across 5 years, with a median of -$89.9 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value jumped 88.64% — and 2023, when it plunged 406.58%.
• Macrogenics' Enterprise Value stood at -$108.9 million in 2022, then increased by 7.28% to -$101.0 million in 2023, then plunged by 81.11% to -$182.8 million in 2024, then soared by 68.71% to -$57.2 million in 2025, then declined by 16.25% to -$66.5 million in 2026.
• Business Quant data shows MGNX's Enterprise Value at -$66.5 million in Q1 2026, -$57.2 million in Q4 2025, and -$80.1 million in Q3 2025.